Nicola Douglass

University Of Cape Town
Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.

A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.

Journal: Human vaccines & immunotherapeutics

Published: April 11, 2025

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Journal: Viruses

Published: December 05, 2024

Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses?

Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses?

Journal: The Lancet. Microbe

Published: April 12, 2024

LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters.

LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters.

Journal: Viruses

Published: May 30, 2023

Development of a dual vaccine against East Coast fever and lumpy skin disease.

Development of a dual vaccine against East Coast fever and lumpy skin disease.

Journal: Frontiers in immunology

Published: January 12, 2023

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.

Journal: Vaccines

Published: December 20, 2022

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.

Journal: Vaccines

Published: September 09, 2021

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.

Journal: Vaccines

Published: September 08, 2021

The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF).

The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF).

Journal: Vaccines

Published: September 06, 2021

Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity.

Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity.

Journal: Vaccines

Published: August 21, 2020

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.

Journal: Nature reviews. Microbiology

Published: August 18, 2020

Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.

Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.

Journal: Vaccine

Published: July 22, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026